0001209191-15-055977.txt : 20150624
0001209191-15-055977.hdr.sgml : 20150624
20150624172103
ACCESSION NUMBER: 0001209191-15-055977
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150622
FILED AS OF DATE: 20150624
DATE AS OF CHANGE: 20150624
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axovant Sciences Ltd.
CENTRAL INDEX KEY: 0001636050
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-532-8833
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
FORMER COMPANY:
FORMER CONFORMED NAME: Axovant Sciences, Inc.
DATE OF NAME CHANGE: 20150324
FORMER COMPANY:
FORMER CONFORMED NAME: Roivant Neurosciences Ltd.
DATE OF NAME CHANGE: 20150309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OLANOFF LAWRENCE S
CENTRAL INDEX KEY: 0001224341
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37418
FILM NUMBER: 15950001
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC.
STREET 2: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-22
0
0001636050
Axovant Sciences Ltd.
AXON
0001224341
OLANOFF LAWRENCE S
C/O AXOVANT SCIENCES, INC.
1441 BROADWAY, 3RD FLOOR
NEW YORK
NY
10018
1
0
0
0
Stock Option (Right to Buy)
20.09
2015-06-22
4
A
0
75000
0.00
A
2025-06-21
Common Shares
75000
75000
D
This option vests over a period of three years, with one third of the common shares underlying the option vesting on May 19, 2016 and the remainder vesting in eight equal quarterly installments thereafter. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
/s/Alison Haggerty, Attorney-in-Fact
2015-06-24